X0609 4 2026-07-16 0001368514 ADMA BIOLOGICS, INC. ADMA 0001872285 Kohler Terry false C/O ADMA BIOLOGICS, INC. 5800 PARK OF COMMERCE BLVD. NW BOCA RATON FL 33487 true CFO and Treasurer false Common Stock 2026-07-16 4 A 0 85130 0 A 143149 D Stock Option (Right to Buy) 8.81 2026-07-16 4 A 0 136363 0 A 2036-07-16 Common Stock 136363 136363 D These shares represent restricted stock units ("RSUs") that will vest quarterly on each annual anniversary of the date of grant over four years in accordance with the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the "Plan"), subject to the Reporting Person's continued service as of the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. Includes, as of the transaction date, (i) 85,130 unvested RSUs granted on July 16, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; and (ii) 58,019 unvested RSUs granted on December 8, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Each RSU represents a contingent right to receive one share of common stock of the Issuer. This option was granted to the Reporting Person on July 16, 2026, and will vest over four years, with 25% of the shares subject to the option vesting on the one-year anniversary of the date of grant, and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, becoming fully vested on July 16, 2030 in accordance with the Plan, subject to the Reporting Person's continued service as of the applicable vesting date. /s/ Terry Kohler, by Michael A. Goldstein as Attorney-in-fact 2026-07-17